Transplantation: rituximab induction for prevention of HLA-antibody rebound.

Sood, Puneet; Hariharan, Sundaram

Sood, Puneet; Hariharan, Sundaram.

Affiliation

Sood P; Department of Medicine and Department of Transplant Surgery, University of Pittsburgh Medical Center, 3459 Fifth Avenue, Pittsburgh, PA 15213, USA.
Hariharan S; Department of Medicine and Department of Transplant Surgery, University of Pittsburgh Medical Center, 3459 Fifth Avenue, Pittsburgh, PA 15213, USA.

Nat Rev Nephrol ; 10(12): 682-3, 2014 12.

Article in En | MEDLINE | ID: mdl-25287429

Subject(s)

Antibodies, Monoclonal, Murine-Derived/administration & dosage; Graft Rejection/prevention & control; HLA Antigens/drug effects; Kidney Transplantation/methods; Transplantation Immunology/drug effects; Case-Control Studies; Desensitization, Immunologic/methods; Female; Graft Survival; HLA Antigens/immunology; Humans; Kidney Transplantation/adverse effects; Living Donors; Male; Prognosis; Retrospective Studies; Risk Assessment; Rituximab; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation Immunology / Kidney Transplantation / Antibodies, Monoclonal, Murine-Derived / Graft Rejection / HLA Antigens Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: Nat Rev Nephrol Journal subject: NEFROLOGIA Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google